References
- Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386:743–800.
- Markus HS, Bevan S. Mechanisms and treatment of ischaemic stroke–insights from genetic associations. Nat Rev Neurol. 2014;10(12):723–730.
- Kopyta I, Sarecka-Hujar B, Sordyl J, et al. The role of genetic risk factors in arterial ischemic stroke in pediatric and adult patients: a critical review. Mol Biol Rep. 2014;41(7):4241–4251.
- Meschia JF, Worrall BB, Rich SS. Genetic susceptibility to ischemic stroke. Nat Rev Neurol. 2011;7(7):369–378.
- Chauhan G, Debette S. Genetic risk factors for ischemic and hemorrhagic stroke. Curr Cardiol Rep. 2016;18(12):124.
- Hutchins AP, Diez D, Miranda-Saavedra D. The IL-10/STAT3-mediated anti-inflammatory response: recent developments and future challenges. Brief Funct Genomics. 2013;12(6):489–498.
- Sanjabi S, Zenewicz LA, Kamanaka M, et al. Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity. Curr Opin Pharmacol. 2009;9(4):447–453.
- Anrather J, Iadecola C. Inflammation and stroke: an overview. Neurotherapeutics. 2016;13(4):661–670.
- Jin R, Liu L, Zhang S, et al. Role of inflammation and its mediators in acute ischemic stroke. J Cardiovasc Trans Res. 2013;6(5):834–851.
- Belisário AR, Sales RR, Toledo NE, et al. Interleukin-10 haplotypes are not associated with acute cerebral ischemia or high-risk transcranial Doppler in a newborn cohort of 395 children with sickle cell anemia. Rev Bras Hematol Hemoter. 2017;39(2):108–114.
- Jiang XH, Lin KX, Zhang YX, et al. Correlating interleukin-10 promoter gene polymorphisms with human cerebral infarction onset. Neural Regen Res. 2015;10:1809–1813.
- Kumar P, Kumar A, Sagar R, et al. Association between interleukin-10 -1082G/A gene polymorphism and risk of stroke in the North Indian population: a case-control study. J Stroke Cerebrovasc Dis. 2016;25(2):461–468.
- Marousi S, Ellul J, Antonacopoulou A, et al. Functional polymorphisms of interleukin 4 and interleukin 10 may predict evolution and functional outcome of an ischaemic stroke. Eur J Neurol. 2011;18(4):637–643.
- Ozkan A, Sılan F, Uludağ A, et al. Tumour necrosis factor alpha, interleukin 10 and interleukin 6 gene polymorphisms of ischemic stroke patients in south Marmara region of Turkey. Int J Clin Exp Pathol. 2015;8(10):13500–13504.
- Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–269.
- Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–605.
- Turner DM, Williams DM, Sankaran D, et al. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997;24(1):1–8.
- de Oliveira JG, Rossi AF, Nizato DM, et al. Influence of functional polymorphisms in TNF-α, IL-8, and IL-10 cytokine genes on mRNA expression level and risk of gastric cancer. Tumor Biol. 2015;36(12):9159–9170.
- Morgan L, Humphries SE. The genetics of stroke. Curr Opin Lipidol. 2005;16(2):193–199.
- Jin J, Li W, Peng L, et al. Relationship between interleukin-10 -1082A/G polymorphism and risk of ischemic stroke: a meta-analysis. PLoS One. 2014;9(4):e94631
- Xie X, Shi X, Liu M. The roles of TLR gene polymorphisms in atherosclerosis: a systematic review and meta-analysis of 35,317 Subjects. Scand J Immunol. 2017;86(1):50–58.
- Wu T, Qiu S, Wang P, et al. The association between vascular endothelial growth factor gene polymorphisms and stroke: a meta-analysis. Brain Behav. 2016;6(7):e00482.
- Hu X, Zan X, Xie Z, et al. Association between plasminogen activator inhibitor-1 genetic polymorphisms and stroke susceptibility. Mol Neurobiol. 2017;54(1):328–341.